1. Aurinia Pharmaceuticals Inc
  2. Aurinia Pharmaceuticals Inc Ownership

Historical shareholding details of Vanguard Russell 2000 Index Fund holdings in Aurinia Pharmaceuticals Inc (AUPH)

Monthly changes of Vanguard Russell 2000 Index Fund shareholding in Aurinia Pharmaceuticals Inc over the previous months

Month Name Total no. shares held Percent Holding
Jul 31, 2025 Vanguard Russell 2000 Index Fund 555,518 0.42%
Jun 30, 2025 Vanguard Russell 2000 Index Fund 599,725 0.46%
May 31, 2025 Vanguard Russell 2000 Index Fund 676,963 0.50%
Apr 30, 2025 Vanguard Russell 2000 Index Fund 670,941 0.50%
Mar 31, 2025 Vanguard Russell 2000 Index Fund 629,694 0.46%
Feb 28, 2025 Vanguard Russell 2000 Index Fund 615,106 0.45%
Jan 31, 2025 Vanguard Russell 2000 Index Fund 596,959 0.43%
Dec 31, 2024 Vanguard Russell 2000 Index Fund 636,383 0.44%
Nov 30, 2024 Vanguard Russell 2000 Index Fund 630,025 0.44%
Oct 31, 2024 Vanguard Russell 2000 Index Fund 613,394 0.43%
Sep 30, 2024 Vanguard Russell 2000 Index Fund 617,202 0.43%
Aug 31, 2024 Vanguard Russell 2000 Index Fund 581,585 0.41%
Jul 31, 2024 Vanguard Russell 2000 Index Fund 566,850 0.40%
Jun 30, 2024 Vanguard Russell 2000 Index Fund 534,496 0.37%
May 31, 2024 Vanguard Russell 2000 Index Fund 506,515 0.35%
Apr 30, 2024 Vanguard Russell 2000 Index Fund 510,457 0.36%
Mar 31, 2024 Vanguard Russell 2000 Index Fund 504,038 0.35%
Feb 29, 2024 Vanguard Russell 2000 Index Fund 492,154 0.34%
Jan 31, 2024 Vanguard Russell 2000 Index Fund 453,702 0.31%
Dec 31, 2023 Vanguard Russell 2000 Index Fund 443,766 0.31%
Nov 30, 2023 Vanguard Russell 2000 Index Fund 417,440 0.29%
Oct 31, 2023 Vanguard Russell 2000 Index Fund 409,594 0.29%
Sep 30, 2023 Vanguard Russell 2000 Index Fund 393,430 0.27%
Aug 31, 2023 Vanguard Russell 2000 Index Fund 389,869 0.27%
Jul 31, 2023 Vanguard Russell 2000 Index Fund 381,586 0.27%
Jun 30, 2023 Vanguard Russell 2000 Index Fund 373,377 0.26%
May 31, 2023 Vanguard Russell 2000 Index Fund 362,646 0.25%
Apr 30, 2023 Vanguard Russell 2000 Index Fund 362,025 0.25%

View all ownership details of Aurinia Pharmaceuticals Inc